Looking for Hypromellose, Unspecified pharmaceutical excipients? Find information on Hypromellose, Unspecified's applications, manufacturers, suppliers, etc. on PharmaCompass.

PharmaCompass

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set

FINISHED DOSAGE FORMULATIONS

Upload your portfolio for free, ask us

FDA Dossiers

read-more
read-more

01

Dosage Form : SOLUTION

SUCROSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : SOLUTION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS :

UNII : C151H8M554

Potency Amount : 0

Potency Unit : NA

blank

02

Dosage Form : SUSPENSION

SUCROSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : SUSPENSION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS :

UNII : C151H8M554

Potency Amount : 22.26

Potency Unit : %

blank

03

Dosage Form : SYRUP

SUCROSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : SYRUP

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS :

UNII : C151H8M554

Potency Amount : 85.46

Potency Unit : %

blank

04

Dosage Form : TABLET

SUCROSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : TABLET

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS :

UNII : C151H8M554

Potency Amount : 182.4

Potency Unit : MG

blank

05

Dosage Form : CAPSULE

SUCROSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS :

UNII : C151H8M554

Potency Amount : 527.43

Potency Unit : MG

blank

06

Dosage Form : CAPSULE, HARD GELATIN

SUCROSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE, HARD GELATIN

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS :

UNII : C151H8M554

Potency Amount : 0

Potency Unit : NA

blank

07

Dosage Form : CAPSULE, SUSTAINED ACTION

SUCROSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE, SUSTAINED ACTION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS :

UNII : C151H8M554

Potency Amount : 17.6

Potency Unit : MG

blank

08

Dosage Form : POWDER, FOR ORAL SUSPENSION

SUCROSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : POWDER, FOR ORAL SUSPENSION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS :

UNII : C151H8M554

Potency Amount : 1195.44

Potency Unit : MG/5ML

blank

09

Dosage Form : POWDER, FOR SUSPENSION

SUCROSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : POWDER, FOR SUSPENSION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS :

UNII : C151H8M554

Potency Amount : 166

Potency Unit : MG/5ML

blank

10

Dosage Form : SUSPENSION, SUSTAINED ACTION

SUCROSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : SUSPENSION, SUSTAINED ACTION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS :

UNII : C151H8M554

Potency Amount : 2323.3

Potency Unit : MG/1PKT

blank
click full view

EXCIPIENTS BY APPLICATIONS

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems Additives

read-more
read-more

Coloring Agents

read-more
read-more

Thickeners And Stabilizers

read-more
read-more

Taste Masking

read-more
read-more

Parenteral

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

MARKET PLACE

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty